Subject: NIH begins recruitment for long-term study of diabetes drug efficacy

 

Having trouble viewing this email? View it as a Web page.

http://links.govdelivery.com/track?type=click&enid=ZWFzPTEmbWFpbGluZ2lkPTIwMTMwNjAzLjE5NDgwOTIxJm1lc3NhZ2VpZD1NREItUFJELUJVTC0yMDEzMDYwMy4xOTQ4MDkyMSZkYXRhYmFzZWlkPTEwMDEmc2VyaWFsPTE3NTk2NjY0JmVtYWlsaWQ9ZHJzcGFyazk5QGFvbC5jb20mdXNlcmlkPWRyc3Bhcms5OUBhb2wuY29tJmZsPSZleHRyYT1NdWx0aXZhcmlhdGVJZD0mJiY=&&&101&&&http://content.govdelivery.com/bulletins/gd/USNIH-7daf57?reqfrom=share

NIH begins recruitment for long-term study of diabetes drug efficacy.   NIH is looking for volunteers to take part in a study to compare the long-term benefits and risks of four widely used type 2 diabetes drugs. There are 3 study sites in NYC: St. Luke's-Roosevelt Hospital Center, Albert Einstein College of Medicine, and New York Hospital--Queens. These sites will enroll a total of 450 participants.  Click here: https://grade.bsc.gwu.edu/home - BSC

 

National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612



To unsubscribe from the NFS-L list, click the following link:
&*TICKET_URL(NFS-L,SIGNOFF);